🇺🇸 FDA
Patent

US 8187606

HPV antigen fusion protein vaccine compositions and uses thereof

granted A61KA61K2039/585A61K2039/6031

Quick answer

US patent 8187606 (HPV antigen fusion protein vaccine compositions and uses thereof) held by Beijing Sunbio Biotech Co. Ltd. expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Beijing Sunbio Biotech Co. Ltd.
Grant date
Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/585, A61K2039/6031, A61K39/12, A61P